Literature DB >> 7064659

Are astrocytes infected in progressive multifocal leukoencephalopathy (PML)?

M Mázló, I Tariska.   

Abstract

Ultrastructural characteristics of the early steps of PML virus infection, i.e. adsorption, penetration, and intracellular virus transport were demonstrated in astrocytes. These phenomena were more frequently seen in the cytoplasm than virus assembly in the nuclei. Infection of the astrocytes is usually non-productive. Light- and electron-microscopic analysis of the present case and 23 cases published in the literature since 1970 leads to the conclusion that the relation is inverse between the appearance of giant, bizarre astrocytes and that of the productive infection of the non-transformed one. The transformation of the astrocytes seems to be induced by infection with the PML virus.

Entities:  

Mesh:

Year:  1982        PMID: 7064659     DOI: 10.1007/bf00691181

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  [Progressive multifocal leucoencephalopathy. Observation with predominant pontocerebellar lesions and association with congenital immune deficiency].

Authors:  F Gagne; J P Bouchard; J P Bernier
Journal:  Acta Neuropathol       Date:  1977-05-16       Impact factor: 17.088

2.  Multiple central nervous system infections in progressive multifocal leukoencephalopathy.

Authors:  T Mathews; H Wisotzkey; J Moossy
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

3.  [Progressive multifocal leukoencephalopathy and multiple gliomas].

Authors:  P Castaigne; P Rondot; R Escourolle; J L Ribadeau dumas; F Cathala; J J Hauw
Journal:  Rev Neurol (Paris)       Date:  1974 Sep-Oct       Impact factor: 2.607

4.  Progressive multifocal leukoencephalopathy. Identification of virions in paraffin-embedded tissues.

Authors:  R Morecki; R S Porro
Journal:  Arch Neurol       Date:  1970-03

5.  Transformation of astrocytes and destruction of spongioblasts induced by a simian tumor virus (SV40) in cultures of human fetal neuroglia.

Authors:  H M Shein
Journal:  J Neuropathol Exp Neurol       Date:  1967-01       Impact factor: 3.685

6.  Primary progressive multifocal leukoencephalopathy. A case report.

Authors:  C F Bolton; B Rozdilsky
Journal:  Neurology       Date:  1971-01       Impact factor: 9.910

7.  [Progressive multifocal leucoencephalopathy. Contribution to the differential diagnosis using electron microscopic and cytophotometric methods].

Authors:  B Krempien; F W Kolkmann; H G Schiemer; P Mayer
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

8.  Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue. Report of a case with unusual light and electron microscopic features.

Authors:  J J Kepes; S M Chou; L W Price
Journal:  Neurology       Date:  1975-11       Impact factor: 9.910

9.  Human papovavirus (JC): induction of brain tumors in hamsters.

Authors:  D L Walker; B L Padgett; G M ZuRhein; A E Albert; R F Marsh
Journal:  Science       Date:  1973-08-17       Impact factor: 47.728

10.  Experimental glioma in primates: a computed tomography model.

Authors:  K G Rieth; G Di Chiro; W T London; J L Sever; S A Houff; P L Kornblith; P E McKeever; C Buonomo; B L Padgett; D L Walker
Journal:  J Comput Assist Tomogr       Date:  1980-06       Impact factor: 1.826

View more
  17 in total

1.  Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.

Authors:  Biswa Nath Sharma; Manfred Marschall; Christine Hanssen Rinaldo
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 2.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

Review 3.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

Review 4.  Natalizumab and progressive multifocal leucoencephalopathy.

Authors:  J R Berger
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

5.  JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy.

Authors:  G L Stoner; C F Ryschkewitsch; D L Walker; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era. A neuropathological comparison using immunocytochemistry and in situ DNA hybridization for virus detection.

Authors:  M Schmidbauer; H Budka; K V Shah
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Synchronous occurrence of glioblastoma multiforme in a husband and wife.

Authors:  T W Griffin; T W Smith; B S Levy; L D Recht
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

8.  Early pathological changes in progressive multifocal leukoencephalopathy: a report of two asymptomatic cases occurring prior to the AIDS epidemic.

Authors:  K E Aström; G L Stoner
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 9.  Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature.

Authors:  R W von Einsiedel; T D Fife; A J Aksamit; M E Cornford; D L Secor; U Tomiyasu; H H Itabashi; H V Vinters
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

10.  An immunohistochemical study of p53 and proliferating cell nuclear antigen expression in progressive multifocal leukoencephalopathy.

Authors:  G A Lammie; A Beckett; R Courtney; F Scaravilli
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.